Catalyst Wire Dossier Catalyst Wire Dossier

Visudyne (verteporfin)

verteporfin · Novartis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Visudyne (verteporfin), covering 2008-05-28 to 2008-05-28. Get the full timeline:

Most recent: Clinical Trial Update: Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD [Phase 2]

See pricing